Shenzhen Chipscreen Biosciences Co., Ltd. (SHA:688321)
China flag China · Delayed Price · Currency is CNY
25.18
-0.11 (-0.43%)
Sep 4, 2026, 3:00 PM CST

SHA:688321 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
-347.75375.55375.9508.98300.55
Short-Term Investments
---257.52181.6100.09
Trading Asset Securities
-295.394.13216.72291.0782.08
Cash & Short-Term Investments
1,514643.05469.69850.14981.65482.71
Cash Growth
166.99%36.91%-44.75%-13.40%103.36%-31.19%
Accounts Receivable
-299.79162.97196.82154.81111.44
Other Receivables
-4.971321.7111.629.17
Receivables
-304.76175.97218.53166.43120.62
Inventory
-57.6840.8447.1328.4715.37
Prepaid Expenses
-----1.69
Other Current Assets
-174.9396.9714.297.5818.43
Total Current Assets
-1,1801,0831,1301,184638.82
Property, Plant & Equipment
-1,2931,1581,0661,100698.99
Long-Term Investments
-228.86245.63268.9429.83-
Other Intangible Assets
-417.82448.29183.99202.8216.18
Long-Term Deferred Tax Assets
-2.91.532.0824.6722.03
Long-Term Deferred Charges
-255.64168.3403.8270.53145.93
Other Long-Term Assets
-271.78146.14148.2783.81172.46
Total Assets
-3,6503,2513,2032,8961,894

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
-3.782.199.030.322.23
Accrued Expenses
-177.5142.03120.277.465.82
Short-Term Debt
-159.8100.22130.11185.78120.15
Current Portion of Long-Term Debt
-342.79133.6636.1919.8817.92
Current Portion of Leases
-3.333.542.842.894.76
Current Income Taxes Payable
---0.1712.0710.77
Current Unearned Revenue
-0.150.170.080.230.29
Other Current Liabilities
-156.5569.592.18241.9671.89
Total Current Liabilities
-843.9451.31390.81540.54293.84
Long-Term Debt
-1,0351,088899.17598.024.88
Long-Term Leases
-4.897.7610.061.291.42
Long-Term Unearned Revenue
-101.483.3577.0486.9678.94
Long-Term Deferred Tax Liabilities
-38.8838.9623.45--
Other Long-Term Liabilities
-0.16092.8393.2997.71
Total Liabilities
-2,0251,6701,4931,320476.79

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
-407.81407.8411.29410.72410.72
Additional Paid-In Capital
-1,0231,0131,1381,0751,125
Retained Earnings
-79.2228.26142.8353.9936.51
Treasury Stock
--15--113.07-154.59-154.59
Comprehensive Income & Other
-130.8131.84131.09130.05-0.29
Total Common Equity
2,5851,6261,5811,7101,5151,418
Minority Interest
----60.23-
Shareholders' Equity
2,5851,6261,5811,7101,5761,418
Total Liabilities & Equity
-3,6503,2513,2032,8961,894

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
1,5441,5461,3341,078807.87149.14
Net Cash (Debt)
-29.37-903.19-863.9-228.24173.78333.58
Net Cash Growth
-----47.90%-48.17%
Net Cash Per Share
-0.07-2.22-2.12-0.560.430.81
Filing Date Shares Outstanding
442.07442.34407.8409.01406.97406.97
Total Common Shares Outstanding
442.07407.27407.8409.01406.97406.97
Working Capital
-336.49632.16739.28643.59344.98
Book Value Per Share
5.843.993.884.183.723.48
Tangible Book Value
2,1741,2081,1331,5261,3131,201
Tangible Book Value Per Share
4.922.972.783.733.232.95
Buildings
-908.16745.57656.92722.9471.88
Machinery
-160.2118.55108.28112.9390.43
Construction In Progress
-351.4384.86360.81308.1157.75